Skip to content

To see the combined effect of Tranexamic acid and Haemocoagulase on blood loss during jaw Surgery.

Evaluation of synergistic effect of Tranexamic acid and Haemocoagulase on intra-operative blood loss during Orthognathic Surgery.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/04/041767
Enrollment
27
Registered
2022-04-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M264- Malocclusion, unspecified

Interventions

Intervention1: Tranexamic acid and haemocoagulase (Combined): Tranexamic acid 5ml(500mg) and haemocoagulase (1ml)/1IU(Combined) in 500ml saline-IV infusion (STAT dose) Pre-Operatively Control Interven

Sponsors

Saveetha dental college and hospitals
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing Orthognathic surgery treatment

Exclusion criteria

Exclusion criteria: Patients undergoing surgeries other than orthognathic surgery

Design outcomes

Primary

MeasureTime frame
Blood loss (Intra-Operative) Postoperative haemoglobin (POST OP.DAY-1) Postoperative haematocrit (POST OP.DAY-1) Time taken for surgery (Intra-Operative) Surgical field assessment (Fromme�s scale) (Intra-Operative)Timepoint: Blood loss (Intra-Operative) Postoperative haemoglobin (POST OP.DAY-1) Postoperative haematocrit (POST OP.DAY-1) Time taken for surgery (Intra-Operative) Surgical field assessment (Fromme�s scale) (Intra-Operative)

Secondary

MeasureTime frame
Intraoperative blood loss during orthognathic surgery Postoperative haemoglobin Postoperative haematocrit Time taken for surgery Surgical field assessment (Fromme�s scale)Timepoint: DAY-0 DAY-1

Countries

India

Contacts

Public ContactProfDrAbdul WahabPU

Saveetha dental college and hospitals

docwahab@hotmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026